Host Dr. Alan Brown discusses fat, exercise and cholesterol with Dr. Harold Bays, medical director and president of Louisville Metabolic and Atherosclerosis Research Center, an independent research center. They look at the properties of adipose tissue — what Dr. Bays calls adiposopathy, or "sick fat." Dr. Bays says that fat cells are very active in terms of helping determine the metabolic rate and subject to dysfunction. They discuss how the location of fat cells and gender of the patient may cause differential problems and may contribute to arteriosclerosis, the effect of exercise on fat and cholesterol, and what kind of exercise is best for overweight patients.
Fat, Exercise and Cholesterol
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Alan Brown discusses fat, exercise and cholesterol with Dr. Harold Bays, medical director and president of Louisville Metabolic and Atherosclerosis Research Center, an independent research center. They look at the properties of adipose tissue — what Dr. Bays calls adiposopathy, or "sick fat." Dr. Bays says that fat cells are very active in terms of helping determine the metabolic rate and subject to dysfunction. They discuss how the location of fat cells and gender of the patient may cause differential problems and may contribute to arteriosclerosis, the effect of exercise on fat and cholesterol, and what kind of exercise is best for overweight patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Updates From the 7th World Symposium Task Force
Partnering with Patients: Building Effective Communication and Support in HF Care
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?